Lupin gets tentative US FDA nod for Enzalutamide tablets
· thehindubusinessline.com
Lupin receives tentative US FDA approval for Enzalutamide Tablets, offering new dosing options as a bioequivalent to Xtandi.
Mumbai-based drugmaker Lupin Ltd on Friday said it has received tentative approval from the US Food and Drug Administration (US FDA) for its abbreviated new dru...